Vyvgart

Vyvgart®

Vyvgart® (efgartigimod alfa-fcab) is a FDA-approved treatment that uses a fragment of an IgG antibody to treat adults with anti-AChR antibody positive generalized myasthenia gravis (gMG).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Argenx

CLASS:
FcRn Inhibitor
WHAT IT TREATS:

Myasthenia Gravis

PRESCRIBED BY:

Neurologists

HOW ADMINISTERED:
Infusion
FREQUENCY:

Once a week for 4 weeks

Length of infusion:
60 mins